Mana.bio, a biotechnology company leveraging artificial intelligence (AI) and nanotechnology for targeted RNA delivery, today announced three poster presentations at the American Society of Gene & ...

Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 ...

"At Mana.bio, we're pioneering the use of AI / ML to design LNP for delivering nucleic acid therapeutics. The data we're presenting at ASGCT demonstrates our ability to rapidly design and optimize ...